BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15734097)

  • 1. Why do women still develop cancer of the cervix despite the existence of a national screening programme?
    Brinkmann D; Gladman MA; Norman S; Lawton FG
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):123-4. PubMed ID: 15734097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Participation in the Dutch national screening programme for uterine cervic cancer higher after invitation by a general practitioner, especially in groups with a traditional low level of attendance].
    de Nooijer DP; de Waart FG; van Leeuwen AW; Spijker WW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2339-43. PubMed ID: 16261714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
    Simcock B; Sykes P; Laney M
    N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening in the Czech Republic.
    Tachezy R; Rob L
    Coll Antropol; 2007 Apr; 31 Suppl 2():27-9. PubMed ID: 17598501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical screening history in patients with early stage carcinoma of the cervix.
    Abed Z; O'Leary M; Hand K; Flannelly G; Lenehan P; Murphy J; Foley M
    Ir Med J; 2006 May; 99(5):140-2. PubMed ID: 16892918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer.
    Belkar R; Fiebig DG; Haas M; Viney R
    Health Econ; 2006 Jan; 15(1):33-47. PubMed ID: 16145719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening history of women in Malmö with invasive cervical cancer.
    Lindqvist PG; Hellsten C; Rippe A
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of cervical screening history data to interpret cervical cancer incidence trends.
    Clare J; Edwards D; Bagnall H; Pearmain P; Lawrence G
    J Public Health (Oxf); 2008 Jun; 30(2):171-7. PubMed ID: 18296455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.